Structured benefit–risk evaluation for medicinal products: review of quantitative benefit–risk assessment findings in the literature

by Marie-Laure Kürzinger, Ludivine Douarin, Ievgeniia Uzun, Chantal El-Haddad, William Hurst, Juhaeri Juhaeri, Stéphanie Tcherny-Lessenot
Published 2020-12-01

Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project

by Matthias Englbrecht, Marie Falahee, Gwenda Simons, Rachael L DiSantostefano, Larissa Valor Méndez, Christine Radawski, Karin Schölin Bywall, Stephanie Tcherny-Lessenot, Ulrik Kihlbom, Brett Hauber, Jorien Veldwijk
Published 2021-04-01